QRLBIO003

Osteoarthritis is a degenerative joint disease. It is the most prevalent kind of arthritis, and older adults are more likely to have it. Osteoarthritis(OA) patients typically experience joint discomfort and stiffness after prolonged inactivity or rest. It is caused when the cartilage and other tissues in the joint degrade or deteriorate over time. The management of osteoarthritis include use of painkillers, lifestyle changes like exercise and weight control, surgical procedures including joint replacement. The prevalence of osteoarthritis is also increasing among the people. In 1990, there were about 23.46 million people with OA in India; by 2019, that number has risen to 62.35 million. With an increasing incidence of OA, effective treatments are needed. QRL Bioscience is developing an autologous cell-based therapy product-QRLBIO003 for treating osteoarthritis.